Parasitic Clearance and Recurrence Rates Among Patients With Vivax Malaria

NCT01784315 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Parasitemia

Interventions

DRUG: Artemisinin combination therapies (ACT)will be used for Chloroquine resistant P.vivax
DRUG: Chloroquine and Primaquine

Sponsor

Ministry of Health, Bhutan

Collaborators

[object Object]
[object Object]